Solana (SOL) traded at $141.67 with a $59.8B market cap, fueled by heightened ETF approval speculation. Invesco’s QSolana (SOL) ETF filing and REX Shares’ REX-Osprey Solana (SOL) Staking ETF, set to ...

In the wake of the catastrophic Texas floods, officials want the public to understand disaster response, rescue and recovery operations.

Fireworks may hit early this summer as Mutuum Finance (MUTM) explodes onto the scene, rapidly becoming one of the top tokens ...

A proposed layout for the initial phase of Rochester's planned sports and recreation complex has been finalized. The Rochester City Council will be asked Monday to approve the schematic design of ...

Marvel Studios' Phase 5 came to an end with Ironheart last week, and we're reflecting on this tumultuous chapter in the ...

After a season of regulatory upheaval, obesity and rare genetic diseases will likely remain major themes for biopharma in ...

New and Unprecedented Survival, Respiratory, and Biomarker Data Prove that NurOwn Helps People with ALS Live Longer and Live ...

Dogecoin is surging, climbing 8% this week to hover around $0.172, sparking chatter about its next move. Technical analysts point to a Parallel Channel pattern, with the memecoin rebounding from the ...

Jazz Pharmaceuticals plc is a Buy with its robust portfolio, potential FDA approvals, and innovative oncology treatments.

Blue Lake Biotechnology, Inc., a clinical-stage intranasal vaccine company developing parainfluenza virus 5 (PIV5)-vectored vaccines that harness the full breadth of the immune system to protect ...

Boehringer Ingelheim today announces the start of the THULITE Phase II clinical study (NCT06962839). It will investigate the efficacy, safety and tolerability of BI 1815368 as a potential oral ...